Matt Davidson
President and CEO, Director at Azora Therapeutics, Inc. (DE) (AZR) since June 2026
Matt Davidson has filed 3 insider reports with the SEC since June 2026, as president and CEO and director at Azora Therapeutics, Inc. (DE) (AZR). The latest filing, on November 4, 2026, reports conversion of a derivative at Azora Therapeutics, Inc. (DE) (AZR).
- Filings
- 3
- Companies
- 1
- Bought on market
- None
- Sold on market
- None
Companies where Matt Davidson is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| President and CEO, Directorsince June 2026 | 819,018 | $3.80 | Nov 4, 2026 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record.
Every filing
- Nov 2, 2026AZRPresident and CEO Davidson Matt converted options into 626,252 shares, increasing direct ownership by 179% to 819,018 unitsForm 4Conversion of a derivative
- Jun 12, 2026AZRChief Development Officer Davidson Matt was granted 297,491 shares and was granted 1,923 units of Series A Preferred StockForm 4Grant or award
- Jun 11, 2026AZRMatt Davidson became an insiderForm 3New insider
Compare Matt Davidson with
- Matt Davidson vs Thomas M Soloway1 shared
- Matt Davidson vs Paul J Hastings1 shared
- Matt Davidson vs Wendy B. Young1 shared
- Matt Davidson vs J. Kermit Anderson1 shared
- Matt Davidson vs Tony Goodman1 shared
- Matt Davidson vs Vinay Shah1 shared
Other insiders at the same companies
- Thomas M SolowayAZR
- Aida HabtezionAZR
- Paul J HastingsAZR
- Julie SaikiAZR
- Coastlands Capital LPAZR
- Wendy B. YoungAZR
- J. Kermit AndersonAZR
- Tony GoodmanAZR
- Kevin SchuylerAZR
- Vinay ShahAZR
- Cary J ClaiborneAZR
- Robertson H. GillilandAZR
- James W. Newman Jr.AZR
Questions about Matt Davidson
- What is Matt Davidson's role at Azora Therapeutics, Inc. (DE)?
- Matt Davidson reports to the SEC as president and CEO and director at Azora Therapeutics, Inc. (DE) (AZR), according to the latest filing on November 4, 2026.
- How many shares does Matt Davidson own?
- After the latest filing that states it, Matt Davidson directly owned 819,018 shares of Azora Therapeutics, Inc. (DE) (AZR). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Matt Davidson bought or sold stock recently?
- No open-market purchases or sales by Matt Davidson are on file. The filings report conversion of a derivative and grant or award.
- How do I get alerts when Matt Davidson files?
- Follow Matt Davidson on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale. Matt Davidson filed 1 time in the last 90 days.
From SEC Forms 3, 4, 5 and 144 filed by Matt Davidson (SEC CIK 0001741937). Totals count each trade once, skipping amendments whose original is on file, from Jun 16, 2026 on. View on SEC EDGAR